Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $4.05 Million - $7.52 Million
-32,002 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $7.03 Million - $11.5 Million
-31,142 Reduced 49.32%
32,002 $8.13 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $3.86 Million - $8.44 Million
-17,412 Reduced 21.61%
63,144 $24.3 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $10.5 Million - $18.9 Million
80,556 New
80,556 $18.9 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $10.1 Million - $17.2 Million
-92,347 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $4.68 Million - $12.1 Million
71,141 Added 335.48%
92,347 $9.65 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $463,900 - $809,734
8,537 Added 67.38%
21,206 $1.5 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $375,889 - $1.01 Million
12,669 New
12,669 $813,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.